Infectious Diseases
2023 Activity indicators
- 2 European H2020 competitive projects: EDCTP2, IMI-COMBACTE-NET
- 13 national competitive public projects: ISCIII
- 16 private led projects
- 66 clinical led studies
- 12 competitive HR contracts
- 110 publications
- IF: 992.80
- Q1 publications: 53 (48%)
- D1 publications: 26 (24%)
- 2 thesis
- 3 awards
- 3 consensus documents, 1 clinical guideline, 3 technical reports, 3 recommendations
- Project evaluators for national institutions: 10 PI
- Project evaluators for international institutions: 7 PI
- Members of editorial committees: 7 PI
- 1 European priority application (21382486.5.) "Differences in salivary ACE2 activity between infected and uninfected adult and pediatric populations exposed to SARS-CoV-2" with extension PCT/EP2023/082280 "Markers associated with the microbiota of high-grade squamous intraepithelial lesions (HSIL)"
- 3 visitors welcomed and 17 months of stay:
- Universidad Politécnica de Madrid
- Open University of Catalonia
- Bahia University (Brazil)
- 12 months of stay in foreign centers:
- University of California San Francisco (USA)
- Vitalant Research Center (San Francisco, USA)
Milestones
- Rotation of two researchers from the group, as part of their competitive contracts, for 6 months at the University of San Francisco/Vitalant Research Institute, San Francisco (United States). An institution of renowned prestige in research ranging from the epidemiology of blood donors to cell therapy and virus discovery.
- Sergio Serrano-Villar et al. Microbiome-derived cobalamin and succinyl-CoA as biomarkers for improved screening of anal cancer. Nat Med. 2023 Jul;29(7):1738-1749. doi: 10.1038/s41591-023-02407-3. PMID: 37464040
- A project to provide an accurate diagnostic test for anal cancer funded by the Fundación la Caixa to Dr. Sergio Serrano.
- The development of the prestigious European MSCA Postdoctoral Fellowship grant awarded to the postdoctoral researcher Elena Moreno and supervised by Dr. Sergio Serrano for the development of the project "MicrobiomE-associaTEd boosters Of immune Responses (METEOR study): experimental characterization and clinical exploitation" has started.
- Success in the AES 2023 Call: 3 health research projects (PI23/01896; PI23/00302; PI23/00099); 4 competitive HR contracts in research; 1 Sara Borrell (CD23/00163), 1 Juan Rodés (JR23/00057), 2 Río Hortega (CM23/00079 and CM23/00045)
Bibliometrics
Article | Accum. FI | Mean FI | Articles Q1 or Q2 | % in Q1 or Q2 | Articles D1 | % on D1 | |
---|---|---|---|---|---|---|---|
2019 | 105 | 371.58 | 3.91 | 67 | 64 | 21 | 20 |
2020 | 112 | 638.63 | 5.70 | 82 | 73 | 36 | 32 |
2021 | 100 | 673.17 | 6.73 | 76 | 76 | 26 | 26 |
2022 | 87 | 800.64 | 9.20 | 64 | 74 | 19 | 22 |
2023 | 110 | 992.80 | 10.24 | 79 | 72 | 26 | 24 |
514 | 23476.80 | 7.16 | 368 | 72 | 128 | 25 |
* Only original articles, editorials, guidelines & reviews